Cost-effectiveness_analysis_of_mass_screening_for_breast_cancer_in_Japan._The_official_Japanese_recommendation_for_breast_cancer_screening_is_physical_examination_by_a_physician,_in_contrast_to_US_recommendations_of_mammography._In_this_analysis_of_breast_cancer_screening,_the_authors_used_Japanese_data_in_a_cost-effectiveness_model_to_compare_the_following_five_strategies:_(1)_no_screening_(N);_(2)_physical_examination_alone_(PE);_(3)_mammography_(MG);_(4)_PE_followed_by_MG_if_PE_findings_were_abnormal_(PE----MG);_and_(5)_PE_combined_with_MG_for_all_screened_women_(PE_+_MG)._None_of_these_programs_would_save_medical_expenditures._The_total_discounted_net_costs_per_patient_(in_US_dollars)_were_as_follows:_N,_+54;_PE,_+412;_MG,_+517;_PE----MG,_+340;_and_PE_+_MG,_+731._The_number_of_years_of_life_saved_per_cohort_of_100,000_asymptomatic_Japanese_women_would_range_from_708_(PE----MG)_to_3724_(PG_+_MG)._The_additional_cost_of_each_strategy_(compared_with_N)_per_additional_year_of_life_would_be_+49,700_for_PE,_+40,400_for_PE----MG,_+14,300_for_MG,_and_+18,000_for_PE_+_MG._The_least_costly_screening_option_(PE----MG)_does_not_have_the_lowest_cost_per_additional_year_of_life_saved_(MG_does)._MG_would_be_preferable_to_the_current_Japanese_recommendation_of_PE_alone.